Preimplantation Genetic Testing Market Size, Share, Analysis Report

1    INTRODUCTION    

    1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

2 Research Methodology 

    2.1 Research Methodology Steps 
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation 
           2.2.1 Research Methodology: Bottom-Up Approach
           2.2.2 Research Methodology: Top-Down Approach
    2.3 Research Design 
    2.4 Data Validation and Triangulation 
           2.4.1 Assumptions for the Study

3 Executive Summary 

4 Premium Insights 

    4.1 Preimplantation Genetic Diagnosis and Screening: Market Overview 
    4.2 Geographic Analysis: Preimplantation Genetic Diagnosis and Screening Market, By Technology (2016) 
    4.3 Preimplantation Genetic Testing Market , By Application, 2018 vs 2024
    4.4 Preimplantation Genetic Testing Market , By Product & Service (2018 vs 2024) 
    4.5 Geographical Snapshot of the Preimplantation Genetic Diagnosis and Screening Market

5 Preimplantation Genetic Testing Market: Overview 

    5.1 Introduction 
    5.2 Market Evolution: Preimplantation Genetic Diagnosis and Screening Technologies 
    5.3 Market Dynamics 
           5.3.1 Major Market Drivers
                    5.3.1.1 Declining Fertility Rates Worldwide
                    5.3.1.2 Increasing Public-Private Investments in the Field of Preimplantation Genetic Testing
                    5.3.1.3 Rising Number of Fertility Clinics Worldwide
                    5.3.1.4 Technological Advancements in the Field of Genetic Analysis
                    5.3.1.5 High Risk of Chromosomal Abnormalities With Advancing Maternal Age
           5.3.2 Major Market Restraints
                    5.3.2.1 High Procedural Cost Associated With Preimplantation Genetic Testing
                    5.3.2.2 Unfavorable Government Regulations
           5.3.3 Major Market Opportunities
                    5.3.3.1 Growth Opportunities in Emerging Markets
                               5.3.3.1.1 Improving Healthcare Infrastructure
                               5.3.3.1.2 Growing Medical Tourism
                               5.3.3.1.3 Growth Initiatives By Key Market Players
                    5.3.3.2 Growing Awareness on Assisted Reproduction Techniques
           5.3.4 Major Market Challenges
                    5.3.4.1 Socioethical Concerns Regarding Preimplantation Genetic Testing
                    5.3.4.2 Procedural Limitations of Preimplantation Genetic Testing With Advancing Age

6 Industry Insights 

    6.1 Value Chain Analysis 
    6.2 Porter’s Five Forces Analysis 
    6.3 Regulatory Scenario

7 Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type 

    7.1 Introduction 
    7.2 Preimplantation Genetic Screening 
    7.3 Preimplantation Genetic Diagnosis

8 Preimplantation Genetic Diagnosis and Screening Market, By Technology 

    8.1 Introduction 
    8.2 Next-Generation Sequencing 
    8.3 Polymerase Chain Reaction 
    8.4 Fluorescence in Situ Hybridization 
    8.5 Comparative Genomic Hybridization 
    8.6 Single-Nucleotide Polymorphism

9 Preimplantation Genetic Diagnosis and Screening Market, By Product and Service 

    9.1 Introduction 
    9.2 Reagents and Consumables 
    9.3 Instruments 
    9.4 Software and Services

10 Preimplantation Genetic Diagnosis and Screening Market, By Application 

     10.1 Introduction 
     10.2 Aneuploidy 
     10.3 Structural Chromosomal Abnormalities 
             10.3.1 Translocations
             10.3.2 Deletions
             10.3.3 Duplications
             10.3.4 Inversions
     10.4 Single Gene Disorders 
     10.5 X-Linked Disorders 
     10.6 HLA Typing 
     10.7 Gender Identification

11 Preimplantation Genetic Diagnosis and Screening Market, By End User 

     11.1 Introduction 
     11.2 Maternity Centers & Fertility Clinics 
     11.3 Hospitals, Diagnostic Labs, and Service Providers 
     11.4 Research Laboratories & Academic Institutes

12 Preimplantation Genetic Diagnosis and Screening Market, By Region 

     12.1 Introduction 
     12.2 North America 
             12.2.1 U.S.
             12.2.2 Canada
     12.3 Europe 
             12.3.1 Germany
             12.3.2 U.K.
             12.3.3 France
             12.3.4 Rest of Europe
     12.4 Asia-Pacific 
             12.4.1 China
             12.4.2 Japan
             12.4.3 India
             12.4.4 Rest of Asia-Pacific
     12.5 Rest of the World

13 Preimplantation Genetic Testing Market: Competitive Landscape 

     13.1 Introduction 
     13.2 Leading Players in the Preimplantation Genetic Testing Market 
     13.3 Competitive Situation and Trends 
             13.3.1 Agreements, Collaborations, and Partnerships
             13.3.2 Product Launches and Approvals
             13.3.3 Acquisitions
             13.3.4 Expansions
             13.3.5 Other Developments
     13.4 Global Preimplantation Genetic Diagnosis and Screening Competitive Leadership Mapping, 2017 
             13.4.1 Visionary Leaders
             13.4.2 Innovators
             13.4.3 Dynamic Differentiators
             13.4.4 Emerging Companies
     13.5 Competitive Leadership Mapping 
             13.5.1 Strength of Product Portfolio (For 25 Players)
             13.5.2 Business Strategy Excellence (For 25 Players)

14 Company Profiles 

     14.1 Top Product Manufacturers 
             14.1.1 Illumina, Inc.
             14.1.2 Thermo Fisher Scientific Inc.
             14.1.3 Agilent Technologies, Inc.
             14.1.4 Perkinelmer, Inc.
             14.1.5 Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)
             14.1.6 ABBott Laboratories
             14.1.7 Natera, Inc.
             14.1.8 Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)
             14.1.9 Oxford Gene Technology
             14.1.10 Yikon Genomics
             14.1.11 Scigene
     14.2 Top Service Provider Companies 
             14.2.1 Beijing Genomics Institute
             14.2.2 Good Start Genetics, Inc.
             14.2.3 Invicta Genetics
             14.2.4 Combimatrix Corporation
             14.2.5 Genea Limited
             14.2.6 Progenesis

The Global Preimplantation Genetic Testing Market has been segmented as below:

By Technology Analysis:

• Next Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescent In-situ Hybridization (FISH)
• Comparative Genomic Hybridization (CGH)
• Single Nucleotide Polymorphism (SNP)

By Product & Service Analysis:

• Reagents & Consumables
• Instruments
• Software & Services

By Procedure Type Analysis:

• Preimplantation Genetic Screening
• Preimplantation Genetic Diagnosis

By Application Analysis:

• Aneuploidy
• Structural Chromosomal Abnormalities
  • Translocations
  • Deletions
  • Duplications
  • Inversions
• Single Gene Disorders
• X-linked Disorders
• HLA Typing
• Gender Identification

By End User Analysis:

• Maternity Centers & Fertility Clinics
• Hospitals, Diagnostic Labs, and Service Providers
• Research Laboratories & Academic Institutes

By Regional Analysis:

• North America
• Europe
• Asia-Pacific
• Rest of the World